Relapse models for clear cell renal carcinoma

Lancet Oncol. 2015 Aug;16(8):e376-8. doi: 10.1016/S1470-2045(15)00090-X.

Authors

Sakshi Gulati¹, Samra Turajlic², James Larkin³, Paul A Bates¹, Charles Swanton⁴

Affiliations

¹ The Francis Crick Institute, London, UK.
² The Francis Crick Institute, London, UK; Renal Unit, The Royal Marsden Hospital, London, UK.
³ Renal Unit, The Royal Marsden Hospital, London, UK.
⁴ The Francis Crick Institute, London, UK; UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, UK. Electronic address: [email protected].

PMID: 26248843
DOI: 10.1016/S1470-2045(15)00090-X

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Renal Cell / genetics*
Female
Humans
Male
Neoplasm Proteins / biosynthesis*
Neoplasm Recurrence, Local / genetics*
Prognosis*

Substances

Neoplasm Proteins

Grants and funding